| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/AJP.149.11.1592 |
| P953 | full work available at URL | http://ajp.psychiatryonline.org/cgi/content/abstract/149/11/1592 |
| P698 | PubMed publication ID | 1415832 |
| P2093 | author name string | P. F. Renshaw | |
| M. Fava | |||
| A. R. Guimaraes | |||
| J. F. Rosenbaum | |||
| J. D. Pearlman | |||
| J. G. Flood | |||
| K. Clancy | |||
| P. R. Puopolo | |||
| R. G. Gonzalez | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluoxetine | Q422244 |
| P304 | page(s) | 1592-1594 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration | |
| P478 | volume | 149 |
| Q37423443 | AGN-2979, an inhibitor of tryptophan hydroxylase activation, does not affect serotonin synthesis in Flinders Sensitive Line rats, a rat model of depression, but produces a significant effect in Flinders Resistant Line rats |
| Q21129108 | Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders |
| Q34094851 | Antidepressant-like action of AGN 2979, a tryptophan hydroxylase activation inhibitor, in a chronic mild stress model of depression in rats |
| Q40971013 | Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function |
| Q40437579 | Are interspecies comparisons in the toxicity of centrally acting drugs valid without brain concentrations? A commentary |
| Q48198530 | Characterization of human brain pharmacokinetics using a two-compartment model |
| Q36781461 | Clinical molecular imaging |
| Q28254262 | Clinical pharmacokinetics of fluoxetine |
| Q46328522 | Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry. |
| Q41570003 | Drug metabolism: from experiments to regulatory aspects |
| Q73718302 | Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies |
| Q51038136 | Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase. |
| Q46395105 | Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). |
| Q40493865 | Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness |
| Q38567315 | Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms |
| Q44193330 | Inhibition of K+ currents of outer hair cells in guinea pig cochlea by fluoxetine |
| Q42256088 | Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms. |
| Q36598509 | MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases |
| Q31054356 | Magnetic resonance spectroscopy in anxiety disorders |
| Q30673059 | Magnetic resonance spectroscopy: current and future applications in psychiatric research |
| Q43593948 | Magnetization transfer of fluoxetine in the human brain using fluorine magnetic resonance spectroscopy |
| Q48162545 | Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy |
| Q41756842 | Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications |
| Q33759563 | Modern chromatographic and electrophoretic measurements of antidepressants and their metabolites in biofluids. |
| Q32136157 | Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice |
| Q34725750 | Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action |
| Q33837768 | Pharmacokinetics of selective serotonin reuptake inhibitors |
| Q33708237 | Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. |
| Q48560352 | Quantitation of dexfenfluramine/d-norfenfluramine concentration in primate brain using 19F NMR spectroscopy |
| Q38926516 | The Role of Metabolites of Antidepressants in the Treatment of Depression |
| Q44506303 | The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3. |
| Q40945435 | The use of toxicokinetics for the safety assessment of drugs acting in the brain |
| Q33738090 | Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice |
| Q45081793 | Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey |
Search more.